ABCB1 and psychotic disorder: Probably, pharmacokinetic interactions between trial agents and antipsychotic drugs, mediated by the activities of cytochrome P450 enzymes56, 57, 58 and p-glycoprotein,59 do not explain the increase in psychosis.